PH
Pharma Mar, S.A. (PHM)
BME
83.85
+1.55 (+1.88%)
Closed
Aug 25, 2026
Day's Range
82.5084.40
52 wk Range
64.00105.20
Financial Statements - PHM - Pharma Mar, S.A.
Revenue
221.39M▲ 26.6%
Net Income
74.98M▲ 187.0%Net Margin 33.9%
EBITDA
69.04M▲ 232.5%
Free Cash Flow
43.75M▲ 561.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 221.39M | 174.85M | 158.15M | 196.34M | 229.83M | 269.96M |
| Cost of Goods | 12.26M | 8.18M | 9.61M | 13.63M | 16.43M | 13.71M |
| Gross Profit | 209.13M | 166.67M | 148.54M | 182.70M | 213.39M | 256.24M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 59.96M | 6.01M | -4.09M | 44.43M | 92.35M | 156.21M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 59.65M | 11.98M | -3.62M | 43.79M | 95.12M | 145.60M |
| Income Tax | -15.33M | -14.14M | -4.76M | -5.56M | 2.27M | 8.34M |
| Net Income | 74.98M | 26.12M | 1.13M | 49.35M | 92.85M | 137.26M |
| EPS Basic | 4.3 | 1.49 | 0.06 | 2.73 | 5.14 | 7.5 |
| EPS Diluted | 4.3 | 1.49 | 0.06 | 2.73 | 5.13 | 7.5 |
| Basic Shares Outstanding | 17.43M | 17.53M | 17.90M | 18.05M | 18.07M | 18.29M |
| Diluted Shares Outstanding | 17.43M | 17.53M | 17.90M | 18.05M | 18.07M | 18.29M |
| Ebit | 62.11M | 14.45M | -1.20M | 46.16M | 98.50M | 148.73M |
| Ebitda | 69.04M | 20.76M | 4.07M | 54.31M | 103.97M | 156.20M |
| Net Income Continuous Operations | 59.65M | 11.98M | -3.62M | 43.79M | 95.12M | 145.60M |
| Minority Interests | - | - | - | - | - | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
